MX2020006995A - Extractos de corteza de abedul que contienen betulina y su formulacion. - Google Patents

Extractos de corteza de abedul que contienen betulina y su formulacion.

Info

Publication number
MX2020006995A
MX2020006995A MX2020006995A MX2020006995A MX2020006995A MX 2020006995 A MX2020006995 A MX 2020006995A MX 2020006995 A MX2020006995 A MX 2020006995A MX 2020006995 A MX2020006995 A MX 2020006995A MX 2020006995 A MX2020006995 A MX 2020006995A
Authority
MX
Mexico
Prior art keywords
extracts
birch bark
betulin
formulation
bark extracts
Prior art date
Application number
MX2020006995A
Other languages
English (en)
Inventor
John Ashleigh Watson
SEBASTIAN JäGER
Tobias Zahn
Original Assignee
Amryt Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amryt Res Limited filed Critical Amryt Res Limited
Publication of MX2020006995A publication Critical patent/MX2020006995A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente descripción se refiere a extractos de corteza de abedul, métodos para producir tales extractos, composiciones farmacéuticas estables que contienen tales extractos y métodos para usar tales extractos. Los extractos de corteza de abedul de la presente descripción contienen triterpenos, que se conocen por mejorar la cicatrización de heridas.
MX2020006995A 2018-01-04 2019-01-04 Extractos de corteza de abedul que contienen betulina y su formulacion. MX2020006995A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862613646P 2018-01-04 2018-01-04
PCT/EP2019/050186 WO2019134982A1 (en) 2018-01-04 2019-01-04 Betulin-containing birch bark extracts and their formulation

Publications (1)

Publication Number Publication Date
MX2020006995A true MX2020006995A (es) 2020-09-09

Family

ID=65031027

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020006995A MX2020006995A (es) 2018-01-04 2019-01-04 Extractos de corteza de abedul que contienen betulina y su formulacion.
MX2023009676A MX2023009676A (es) 2018-01-04 2020-07-13 Extractos de corteza de abedul que contienen betulina y su formulacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023009676A MX2023009676A (es) 2018-01-04 2020-07-13 Extractos de corteza de abedul que contienen betulina y su formulacion.

Country Status (13)

Country Link
US (5) US20200330481A1 (es)
EP (2) EP4249057A3 (es)
JP (2) JP7358353B2 (es)
KR (1) KR20200106487A (es)
CN (1) CN111356479A (es)
AU (1) AU2019205091A1 (es)
BR (1) BR112020009867A2 (es)
CA (1) CA3081624A1 (es)
CO (1) CO2020006242A2 (es)
IL (1) IL275631A (es)
MX (2) MX2020006995A (es)
SG (1) SG11202003668YA (es)
WO (1) WO2019134982A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111356479A (zh) 2018-01-04 2020-06-30 安瑞特研究有限公司 含有白桦脂醇的桦树皮提取物及其制剂

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2764620A (en) 1951-12-04 1956-09-25 Phillips Petroleum Co Adsorption process with heating in downstream end of adsorption column to selectively remove occluded liquids
LU47604A1 (es) 1964-12-17 1966-06-17
US4044031A (en) 1976-07-02 1977-08-23 Ake Allan Johansson Process for the separation of sterols
FI57956C (fi) 1978-12-12 1980-11-10 Farmos Oy Foerfarande foer isolering av beta-sitosterol med laog alfa-sitosterolhalt
FR2487356A1 (fr) 1980-07-25 1982-01-29 Oreal Emulsions stables obtenues a partir d'un agent emulsionnant naturel stabilise par du suc d'aloes
LU83173A1 (fr) 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JPS597106A (ja) 1982-07-06 1984-01-14 Shiseido Co Ltd 乳化組成物
JPS5967212A (ja) 1982-10-12 1984-04-16 Kazuo Suga 化粧品組成物
JPS59206496A (ja) 1983-05-11 1984-11-22 ライオン株式会社 シヤンプ−組成物
FI77441C (fi) 1985-03-04 1989-03-10 Kemira Oy Foerfarande foer omvandling av vaextmaterial till kemikalier.
JPS61205204A (ja) 1985-03-08 1986-09-11 Shiseido Co Ltd 皮膚外用剤
US5166176A (en) 1986-12-29 1992-11-24 Obagi Zein E Composition for healing damaged skin
US5567419A (en) 1988-12-22 1996-10-22 Kanebo Ltd. Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin
JP2652228B2 (ja) 1988-12-22 1997-09-10 鐘紡株式会社 化粧料
ES2115665T3 (es) 1991-01-29 1998-07-01 Shionogi & Co Derivado de triterpeno.
GB9104286D0 (en) 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
JPH0597106A (ja) 1991-10-07 1993-04-20 Youka Tekko Kk 球状物包装装置
DE4318280A1 (de) 1993-06-02 1993-12-16 Ivo Stane Hautpflegemittel auf natürlicher Basis
US5660727A (en) 1994-06-14 1997-08-26 Dionex Corporation Automated analyte supercritical fluid extraction apparatus
US5843311A (en) 1994-06-14 1998-12-01 Dionex Corporation Accelerated solvent extraction method
US5647976A (en) 1995-03-03 1997-07-15 Dionex Corporation High pressure and temperature cell for solvent extraction
DE69623914T2 (de) 1995-07-12 2003-05-15 Shiseido Co Ltd Äusserliches hautpräparat
DE19544905A1 (de) 1995-12-01 1997-06-05 Robugen Gmbh Verfahren zur Herstellung von Pflanzenextrakten
JPH09179354A (ja) 1995-12-27 1997-07-11 Minolta Co Ltd 液体現像剤用トナー、液体現像剤、およびその製造方法
US5882916A (en) 1996-02-15 1999-03-16 Nouveau Technolgies, Inc. Decontamination process
JPH09235293A (ja) 1996-02-29 1997-09-09 Kanebo Ltd 新規トリテルペン
AU3692097A (en) 1996-08-02 1998-02-25 Plum Kemi Produktion A/S An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin
JPH10152444A (ja) 1996-11-22 1998-06-09 Nippon Flour Mills Co Ltd メイラード反応抑制剤及び化粧料
WO1998032443A1 (de) 1997-01-24 1998-07-30 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten enthaltend antitumoral, antiviral und antiparasitär wirksame ester von pentacyclischen triterpenen
WO1998033494A1 (en) 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
DE19713768B4 (de) 1997-04-03 2006-07-13 Martin-Luther-Universität Halle-Wittenberg Herstellung von Betulinsäure
US6403816B1 (en) 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
US6022890A (en) 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
FR2779438B1 (fr) 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
US6124362A (en) 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6746695B1 (en) 1998-10-02 2004-06-08 Armadillo Pharmaceuticals, Inc. Pharmaceutical preparations of bioactive substances extracted from natural sources
CA2250481A1 (fr) 1998-11-02 2000-05-02 Andre Pichette Procede de preparation de derives du betulinol directement a partir de l'ecorce du bouleau blanc
GB9908593D0 (en) 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
DK1200106T3 (da) 1999-07-09 2003-10-27 Bsp Pharma As Præparat indeholdende Butyrospermum parkii-ekstrakter og anvendelse deraf som lægemiddel eller kosttilskud
US6392070B1 (en) 1999-08-10 2002-05-21 Regents Of The University Of Minnesota Birch bark processing and the isolation of natural products from birch bark
WO2001019365A1 (en) 1999-09-15 2001-03-22 Roche Consumer Health Ag Pharmaceutical and/or cosmetical compositions
AU768306B2 (en) 1999-10-14 2003-12-04 Nisshin Oil Mills, Ltd., The Skin-care agents, skin antiaging agents, whitening agents and external skin preparations
DE60102402T2 (de) 2000-02-10 2005-03-10 Loders Croklaan B.V. Fettmischungen mit Kristallmodifikatoren
US6264998B1 (en) 2000-03-01 2001-07-24 Dabur Research Foundation Extracting betulinic acid from Ziziphus jujuba
EP1267900B1 (de) * 2000-03-28 2004-04-21 Birken Gmbh Emulsion enthaltend einen triterpen-haltigen pflanzenextrakt, verfahren zur herstellung der emulsion sowie zur gewinnung des pflanzenextraktes
DE10056902A1 (de) 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
WO2001072265A1 (fr) 2000-03-31 2001-10-04 The Nisshin Oil Mills, Ltd. Preparation externe pour la peau et agents d'embellissement
WO2002026762A1 (en) 2000-09-29 2002-04-04 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
WO2002026761A1 (en) 2000-09-29 2002-04-04 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10108387A1 (de) 2001-02-21 2002-08-29 Basf Ag Kosmetisches oder pharmazeutisches Mittel
DE10143964A1 (de) 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
DE10317400B4 (de) 2003-04-15 2006-04-13 Universitätsklinikum Hamburg-Eppendorf EX-VIVO-Hautorganmodell aus Schweinehaut
DE10329955A1 (de) 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung
DE102004030044A1 (de) 2004-06-22 2006-01-12 Birken Gmbh Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
US8293710B2 (en) 2005-01-03 2012-10-23 Blue Blood Biotech Corp. Method for treating wounds using an EGF-like domain of thrombomodulin
US20090041859A1 (en) 2005-04-08 2009-02-12 Mie University Wound Treatment Drugs for External Use
WO2006133314A2 (en) 2005-06-08 2006-12-14 Regents Of The University Of Minnesota Synthesis of betulonic and betulinic aldehydes
WO2006133395A2 (en) 2005-06-08 2006-12-14 Regents Of The University Of Minnesota Stereoselective reduction of triterpenones
BRPI0613227A2 (pt) 2005-06-09 2011-01-04 Chiang Chuan Chi uma composição para cicatrização de ferida e uso desta
EP1889608B1 (en) 2006-08-09 2012-11-28 Korea Atomic Energy Research Institute Therapeutic hydrogel for atopic dermatitis and preparation method thereof
DE102006049929B4 (de) 2006-10-19 2012-03-08 Beiersdorf Ag Filmbildende Gelkomposition zur Wund- bzw. Hautpflege
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
GB2455585B (en) 2008-01-16 2010-07-28 Ali Reza Rezai-Fard Capsicum seeds for the treatment of eczema and dermatitis
CN101664562A (zh) 2009-09-30 2010-03-10 都本立 创伤修复水凝胶材料及制备方法
DE102009047092A1 (de) 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
PL2363108T3 (pl) 2010-03-02 2018-04-30 Neubourg Skin Care Gmbh & Co. Kg Formulacje piankowe zawierające co najmniej jeden triterpenoid
CN103439446A (zh) 2013-08-13 2013-12-11 张家港威胜生物医药有限公司 使用rp-hplc法测定桦树皮中桦木醇含量的方法
GB201400292D0 (en) * 2014-01-08 2014-02-26 Haemostatix Ltd Peptide dendrimers and agents
WO2017147067A1 (en) * 2016-02-22 2017-08-31 Board Of Regents, The University Of Texas System Antimicrobial compositions and uses thereof
US20190183797A1 (en) 2016-07-18 2019-06-20 Rolf Daniels Betulin-containing water-in-oil foams and compositions thereof
RU2635533C1 (ru) 2016-09-08 2017-11-13 Общество с ограниченной ответственностью Управляющая компания "МЕРЕЯ ГРУПП" Повязка для закрытия и лечения ран
CN111356479A (zh) 2018-01-04 2020-06-30 安瑞特研究有限公司 含有白桦脂醇的桦树皮提取物及其制剂

Also Published As

Publication number Publication date
KR20200106487A (ko) 2020-09-14
US20210369733A1 (en) 2021-12-02
US20210093647A1 (en) 2021-04-01
AU2019205091A1 (en) 2020-04-30
US20200330481A1 (en) 2020-10-22
IL275631A (en) 2020-08-31
SG11202003668YA (en) 2020-05-28
JP2023168437A (ja) 2023-11-24
US11826374B2 (en) 2023-11-28
MX2023009676A (es) 2023-08-25
JP7358353B2 (ja) 2023-10-10
US20220184097A1 (en) 2022-06-16
US20240050445A1 (en) 2024-02-15
JP2021509891A (ja) 2021-04-08
CO2020006242A2 (es) 2020-05-29
RU2020125679A (ru) 2022-02-04
CA3081624A1 (en) 2019-07-11
EP4249057A3 (en) 2023-11-29
CN111356479A (zh) 2020-06-30
US11083733B2 (en) 2021-08-10
EP3735274A1 (en) 2020-11-11
US11266660B2 (en) 2022-03-08
WO2019134982A1 (en) 2019-07-11
BR112020009867A2 (pt) 2020-11-03
EP4249057A2 (en) 2023-09-27

Similar Documents

Publication Publication Date Title
PH12019501824A1 (en) Anti-gprc5d antibody and molecule comprising the antibody
MX2018015892A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2019015744A (es) Composiciones farmaceuticas.
EA201692334A1 (ru) Кортикостероидные композиции для местного применения
MX2020006612A (es) Compuesto que funciona como inhibidor de proteína de bromodominio y composición.
PH12018500374A1 (en) Antimicrobial compositions and formulations releasing hydrogen peroxide
PH12020550341A1 (en) Niraparib formulations
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
EA201991799A1 (ru) Диспергируемые в воде составы
BR112018071831A2 (pt) composições anti-irritantes sinérgicas de taurina e aloé e métodos
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
WO2017136617A8 (en) Deuterated domperidone compositions and methods for therapy of disorders
EP4327880A3 (en) Solid state form of ribociclib succinate
PH12020550703A1 (en) Sulfonamide compounds and use thereof
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
MX2023009676A (es) Extractos de corteza de abedul que contienen betulina y su formulacion.
WO2018237135A3 (en) PROCESS FOR THE PREPARATION OF A NORMALIZED COMPOSITION OF ARJUNOGLUCOSIDE FROM THE BARK OF TERMINALIA ARJUNA
MX2021005910A (es) Formulacion de proteina de alta concentracion.
KR20180084522A (ko) 프로폴리스, 모링가 및 상엽 혼합 추출물을 유효성분으로 함유하는 화장료 조성물
PH12019500024A1 (en) Pharmaceutical compositions
MX2020010320A (es) Composiciones de erenumab y usos de las mismas.
CA3081484A1 (en) Finished fibrous structures and methods of their use and preparation
CO2021008962A2 (es) Derivados activos de éster de testosterona, composiciones y usos de los mismos
MX2018008069A (es) Composicion lipida vegetal para promover el crecimiento del cabello, metodo para promover el crecimiento del cabello y uso de los lipidos vegetales.
MX2022001805A (es) Formulaciones de anticuerpos anti-esclerostina.